Study of the Photostability of Sodium Montelukast Under Controlled Stress Conditions
Palavras-chave:
photostability, montelukast, light, degradation, stress conditionsResumo
Montelukast Sodium is a drug widely used in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Although its therapeutic efficacy is well established, the stability of the drug under different environmental conditions, especially exposure to light, has raised increasing concerns.
This study evaluated the photostability of montelukast sodium under different wavelengths and light doses. Drug degradation was monitored using UV-Vis spectrophotometry and high-performance liquid chromatography (HPLC). The results provide essential information for optimizing the storage and handling conditions of montelukast sodium, ensuring its efficacy and safety. This study is essential for the development of guidelines to ensure the drug’s stability throughout clinical use.
Referências
ALBINI, A.; FASANI, E. (Ed.). Drugs, photochemistry and photostability. Cambridge: Royal Society of Chemistry, 1998. 326 p. (Special Publication, n. 225) [International Meeting on Photostability of Drugs, 2., Pavia, 1997].
ALSANTE, K. M.; MARTIN, L.; BAERTSCHI, S. W. A stress testing benchmarking study. Pharmaceutical Technology, v. 1, p. 60-72, 2003.
ALSANTE, K. M.; ANDO, A.; BROWN, R.; ENSING, J.; HATAJIK, T. D.; KONG, W.; TSUDA, Y. The role of degradant profiling in active pharmaceutical ingredients and drug products. Advanced Drug Delivery Reviews, v. 59, p. 29-37, 2007.
ANDERSON, N. H.; BYARD, S. J. Photostability testing: design and interpretation of tests on new drug substances and dosage forms. In: TONNESEN, H. H. (Ed.). Photostability of drugs and drug formulations. 2nd ed. Boca Raton: CRC Press, 2004. chap. 6, pp. 137-159.
AZEVEDO FILHO, C. A.; FILGUEIRAS GOMES, D.; MÉLO GUEDES, J. P.; MUNIZ FALCÃO BATISTA, R.; SAGESSER SANTOS, B. Considerations on the quinine actinometry calibration method used in photostability testing of pharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis, v. 54, pp. 886-888, 2011.
